Lyvgen Biopharma
Lyvgen Biopharma is a Healthcare Company.
Launch date
Employees
Market cap
-
Enterprise valuation
$150m (Public information from Feb 2021)
Shanghai Shanghai (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$30.0m | Series B | ||
$20.0m Valuation: $150m | Series C | ||
Total Funding | $50.0m |
Recent News about Lyvgen Biopharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.